Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021, 165(3):305-315 | DOI: 10.5507/bp.2020.041

Transabdominal amniocentesis in expectant management of preterm premature rupture of membranes: A single center prospective study

Veronika Fulovaa, Eliska Hostinskaa, Martina Studnickovaa, Karel Humla, Jana Zapletalovab, Jan Halekc, Radovan Pilka
a Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, I. P. Pavlova 6, 775 20 Olomouc, Czech Republic
b Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic
c Department of Neonatology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, I. P. Pavlova 6, 775 20 Olomouc, Czech Republic

Aims: The aim of this study was to evaluate the role of IL-6 point-of-care test in amniotic fluid obtained from serial amniocentesis in expectantly managed women with PPROM between 24 and 34 weeks of gestation.

Methods: We conducted a prospective observational cohort study which included 62 pregnant women with PPROM in gestational weeks between 22+0 and 34+0. Women aged >18 years were eligible if they presented with PPROM and a singleton pregnancy. Only women who delivered at >24.0 weeks were included in the study. In all women, the maternal blood sampling and a transabdominal amniocentesis were performed at the time of admission prior to the administration of corticosteroids, antibiotics, or tocolytics, to rule out signs of chorioamnionitis. Maternal temperature, maternal serum C-reactive protein (CRP) and white blood cell (WBC) counts were assayed every subsequent day until delivery. Amniotic fluid was used for the clinical assessment (IL-6 point-of-care test, identification of microorganisms in the amniotic fluid. After one week of expectant management of PPROM, second amniocentesis with amniotic fluid sampling was performed in patients who did not deliver. For all newborns, medical records regarding neonatal morbidity and mortality were reviewed.

Results: In total, 62 women aged 19 to 41 years were recruited in the study. The mean gestational age at the time of PPROM was 31+0, the mean gestational age at labor was 32+1, and the median time from PPROM to childbirth was 112 h. IL-6 point-of-care test values above 1,000 pg/mL (positive Il-6 AMC) were found in 12 women (19.4%) with median interval from PPROM to childbirth 56 h (min-max: 6.4-288). IL-6 point-of-care test values below 1,000 pg/mL (negative Il-6 AMC) were found in 51 women (81.0%). The neonatal mortality rate was 1.9% and was associated with prematurity.

Conclusion: The major clinical finding of our study is that serial transabdominal amniocentesis with Il-6 point-of-care test helps to identify a high inflammatory status in amniotic fluid in women with PPROM. Subsequent expectant management of women with PPROM does not lead to worsening of short-term neonatal outcomes.

Keywords: PPROM, Il-6, poin-of-care test, amniocentesis

Received: February 21, 2020; Revised: August 31, 2020; Accepted: September 15, 2020; Prepublished online: October 1, 2020; Published: September 20, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fulova, V., Hostinska, E., Studnickova, M., Huml, K., Zapletalova, J., Halek, J., & Pilka, R. (2021). Transabdominal amniocentesis in expectant management of preterm premature rupture of membranes: A single center prospective study. Biomedical papers165(3), 305-315. doi: 10.5507/bp.2020.041
Download citation

References

  1. Kacerovský M, Koucký M, Křepelka P, Lamberská T, Mašata J, Měchurová A, Pařízek A, Smíšek J, Šimják P, Velebil P. Předčasný odtok plodové vody před termínem porodu. Doporučený postup. Ceska Gynekol 2017;82(2):166-7. (In Czech)
  2. Kacerovsky M, Drahosova M, Hornychova H, Pliskova L, Bolehovska R, Forstl M, Tosner J, Lesko D, Andrys C. Amniotic fluid interleukin 6 levels in preterm premature rupture of membranes. Ceska Gynekol 2009;74(6):403-10. (In Czech)
  3. Kacerovsky M, Musilova I. Management of preterm prelabor rupture of membranes with respect to the inflammatory complications - our experiences. Ceska Gynekol 2013;78(6):509-13. (In Czech)
  4. Kuba K, Bernstein PS. ACOG Practice Bulletin No. 188: Prelabor Rupture of Membranes. Obstet Gynecol 2018;131(6):1163-64. doi:10.1097/AOG.0000000000002663 Go to original source... Go to PubMed...
  5. Pettit KE, Caballero A, Wakefield BW, Dudley DJ, Ferguson JE, 2nd, Boyle A, Chisholm CA. Targeted delivery at 34 versus 35 weeks in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2019;32(20):3331-35. doi: 10.1080/14767058.2018.1463365. Go to original source... Go to PubMed...
  6. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015;213(4 Suppl):S29-52. doi: 10.1016/j.ajog.2015.08.040. Go to original source... Go to PubMed...
  7. Kacerovsky M, Tosner J, Andrys C, Drahosova M, Pliskova L, Forstl M, Hornychova H. [Amniotic fluid heat shock protein 70 concentration in preterm premature rupture of membranes]. Ceska Gynekol 2009;74(2):85-91.
  8. Kacerovsky M, Pliskova L, Bolehovska R, Skogstrand K, Hougaard DM, Tsiartas P, Jacobsson B. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation. Am J Obstet Gynecol 2012;206(4):342 e1-8. doi: 10.1016/j.ajog.2012.01.004 Go to original source... Go to PubMed...
  9. Dollner H, Vatten L, Halgunset J, Rahimipoor S, Austgulen R. Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. BJOG 2002;109(5):534-9. Go to original source...
  10. Kacerovsky M, Celec P, Vlkova B, Skogstrand K, Hougaard DM, Cobo T, Jacobsson B. Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria. PLoS One 2013;8(3):e60399. doi: 10.1371/journal.pone.0060399 Go to original source... Go to PubMed...
  11. Kacerovsky M, Musilova I, Khatibi A, Skogstrand K, Hougaard DM, Tambor V, Tosner J, Jacobsson B. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2012;25(10):2014-9. doi: 10.3109/14767058.2012.671873 Go to original source... Go to PubMed...
  12. Bredeson S, Papaconstantinou J, Deford JH, Kechichian T, Syed TA, Saade GR, Menon R. HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes. PLoS One 2014;9(12):e113799. doi: 10.1371/journal.pone.0113799 Go to original source... Go to PubMed...
  13. Sprong KE, Mabenge M, Wright CA, Govender S. Ureaplasma species and preterm birth: current perspectives. Crit Rev Microbiol 2020:1-13. doi: 10.1080/1040841X.2020.1736986 Go to original source... Go to PubMed...
  14. Kacerovsky M, Cobo T, Andrys C, Musilova I, Drahosova M, Hornychova H, Janku P, Jacobsson B. The fetal inflammatory response in subgroups of women with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2013;26(8):795-801. doi: 10.3109/14767058.2013.765404 Go to original source... Go to PubMed...
  15. Kacerovsky M, Vlkova B, Musilova I, Andrys C, Pliskova L, Zemlickova H, Stranik J, Halada P, Jacobsson B, Celec P. Amniotic fluid cell-free DNA in preterm prelabor rupture of membranes. Prenat Diagn 2018;38(13):1086-95. doi: 10.1002/pd.5366 Go to original source... Go to PubMed...
  16. Chaemsaithong P, Romero R, Korzeniewski SJ, Martinez-Varea A, Dong Z, Yoon BH, Hassan SS, Chaiworapongsa T,Yeo L. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection. J Matern Fetal Neonatal Med 2016;29(3):360-7. doi: 10.3109/14767058.2015.1006621 Go to original source... Go to PubMed...
  17. Romero R, Yoon BH, Kenney JS, Gomez R, Allison AC, Sehgal PB. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993;30(2-3):167-83. doi: 10.1111/j.1600-0897.1993.tb00618.x Go to original source... Go to PubMed...
  18. Romero R, Miranda J, Kusanovic JP, Chaiworapongsa T, Chaemsaithong P, Martinez A, Gotsch F, Dong Z, Ahmed AI, Shaman M, Lannaman K, Yoon BH, Hassan SS, Kim CJ, Korzeniewski SJ, Yeo L, Kim YM. Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques. J Perinat Med 2015;43(1):19-36. doi: 10.1515/jpm-2014-0249 Go to original source... Go to PubMed...
  19. Aviram A, Quaglietta P, Warshafsky C, Zaltz A, Weiner E, Melamed N, Ng E, Barrett J, Ronzoni S. The utility of ultrasound assessment in the management of preterm prelabor rupture of the membranes. Ultrasound Obstet Gynecol 2020;55(6):806-14. doi: 10.1002/uog.20403 Go to original source... Go to PubMed...
  20. Marcellin L, Anselem O, Guibourdenche J, De la Calle A, Deput-Rampon C, Cabrol D, Tsatsaris V. [Comparison of two bedside tests performed on cervicovaginal fluid to diagnose premature rupture of membranes]. J Gynecol Obstet Biol Reprod (Paris) 2011;40(7):651-6. doi: 10.1016/j.jgyn.2011.06.007 Go to original source... Go to PubMed...
  21. Musilova I, Pliskova L, Gerychova R, Janku P, Simetka O, Matlak P, Jacobsson B, Kacerovsky M. Maternal white blood cell count cannot identify the presence of microbial invasion of the amniotic cavity or intra-amniotic inflammation in women with preterm prelabor rupture of membranes. PLoS One 2017;12(12):e0189394. doi: 10.1371/journal.pone.0189394 Go to original source... Go to PubMed...
  22. Kacerovsky M, Musilova I, Hornychova H, Kutova R, Pliskova L, Kostal M, Jacobsson B. Bedside assessment of amniotic fluid interleukin-6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol 2014;211(4):385.e1-9. doi:10.1016/j.ajog.2014.03.069 Go to original source... Go to PubMed...
  23. Vousden N, Chandiramani M, Seed P, Shennan A. Interleukin-6 bedside testing in women at high risk of preterm birth. J Matern Fetal Neonatal Med 2011;24(10):1301-4. doi: 10.3109/14767058.2011.558954 Go to original source... Go to PubMed...
  24. Musilova I, Andrys C, Holeckova M, Kolarova V, Pliskova L, Drahosova M, Bolehovska R, Pilka R, Huml K, Cobo T, Jacobsson B, Kacerovsky M. Interleukin-6 measured using the automated electrochemiluminescence immunoassay method for the identification of intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2020;33(11):1919-26. doi: 10.1080/14767058.2018.1533947 Go to original source... Go to PubMed...
  25. Erdemir G, Kultursay N, Calkavur S, Zekioglu O, Koroglu OA, Cakmak B, Yalaz M, Akisu M, Sagol S. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol 2013;54(4):267-74. doi: 10.1016/j.pedneo.2013.03.012 Go to original source... Go to PubMed...
  26. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C, Society for Pediatric Pathology PSAFINC. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003;6(5):435-48. doi: 10.1007/s10024-003-7070-y Go to original source... Go to PubMed...
  27. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989;73(3 Pt 1):383-9. Go to original source... Go to PubMed...
  28. Kim CJ, Romero R, Chaemsaithong P, Kim JS. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol 2015;213(4 Suppl):S53-69. doi: 10.1016/j.ajog.2015.08.041 Go to original source... Go to PubMed...
  29. Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP, Baumann P, Araneda H, Kenney JS, Cotton DB. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169(4):839-51. doi: 10.1016/0002-9378(93)90014-a Go to original source... Go to PubMed...
  30. Musilova I, Kutova R, Pliskova L, Stepan M, Menon R, Jacobsson B, Kacerovsky M. Intraamniotic Inflammation in Women with Preterm Prelabor Rupture of Membranes. PLoS One 2015;10(7):e0133929. doi: 10.1371/journal.pone.0133929 Go to original source... Go to PubMed...
  31. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982;389:406-18. doi: 10.1111/j.1749-6632.1982.tb22153.x Go to original source... Go to PubMed...
  32. Cobo T, Jacobsson B, Kacerovsky M, Hougaard DM, Skogstrand K, Gratacos E, Palacio M. Systemic and local inflammatory response in women with preterm prelabor rupture of membranes. PLoS One 2014;9(1):e85277. doi: 10.1371/journal.pone.0085277 Go to original source... Go to PubMed...
  33. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG 2007;114(7):796-801. doi: 10.1111/j.1471-0528.2007.01385.x Go to original source... Go to PubMed...
  34. Stepan M, Cobo T, Musilova I, Hornychova H, Jacobsson B, Kacerovsky M. Maternal Serum C-Reactive Protein in Women with Preterm Prelabor Rupture of Membranes. PLoS One 2016;11(3):e0150217. doi: 10.1371/journal.pone.0150217 Go to original source... Go to PubMed...
  35. Kidokoro K, Furuhashi M, Kuno N, Ishikawa K. Amniotic fluid neutrophil elastase and lactate dehydrogenase: association with histologic chorioamnionitis. Acta Obstet Gynecol Scand 2006;85(6):669-74. doi: 10.1080/01443610600604432 Go to original source... Go to PubMed...
  36. Popowski T, Goffinet F, Batteux F, Maillard F, Kayem G. [Prediction of maternofetal infection in preterm premature rupture of membranes: serum maternal markers]. Gynecol Obstet Fertil 2011;39(5):302-8. doi: 10.1016/j.gyobfe.2010.11.006 Go to original source... Go to PubMed...
  37. Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993;6(1):69-87. doi:10.1128/cmr.6.1.69 Go to original source... Go to PubMed...
  38. Gupta A, Gupta A, Gupta S, Mittal A, Chandra P,Gill AK. Correlation of mycoplasma with unexplained infertility. Arch Gynecol Obstet 2009;280(6):981-5. doi:10.1007/s00404-009-1042-z Go to original source... Go to PubMed...
  39. Prince AL, Ma J, Kannan PS, Alvarez M, Gisslen T, Harris RA, Sweeney EL, Knox CL, Lambers DS, Jobe AH, Chougnet CA, Kallapur SG,Aagaard KM. The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis. Am J Obstet Gynecol 2016;214(5):627.e1-627e16. doi: 10.1016/j.ajog.2016.01.193 Go to original source... Go to PubMed...
  40. Sweeney EL, Kallapur SG, Gisslen T, Lambers DS, Chougnet CA, Stephenson SA, Jobe AH, Knox CL. Placental Infection With Ureaplasma species Is Associated With Histologic Chorioamnionitis and Adverse Outcomes in Moderately Preterm and Late-Preterm Infants. J Infect Dis 2016;213(8):1340-7. doi: 10.1093/infdis/jiv587 Go to original source... Go to PubMed...
  41. Pavlidis I, Spiller OB, Sammut Demarco G, MacPherson H, Howie SEM, Norman JE, Stock SJ. Cervical epithelial damage promotes Ureaplasma parvum ascending infection, intrauterine inflammation and preterm birth induction in mice. Nat Commun 2020;11(1):199. doi: 10.1038/s41467-019-14089-y Go to original source... Go to PubMed...
  42. Amon E, Lewis SV, Sibai BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988;159(3):539-43. doi: 10.1016/s0002-9378(88)80002-4 Go to original source... Go to PubMed...
  43. Kwak HM, Shin MY, Cha HH, Choi SJ, Lee JH, Kim JS, Roh CR, Kim JH, Oh SY. The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes. Placenta 2013;34(4):346-52. doi: 10.1016/j.placenta.2013.01.016 Go to original source... Go to PubMed...
  44. Lee J, Romero R, Kim SM, Chaemsaithong P, Yoon BH. A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM. J Matern Fetal Neonatal Med 2016;29(17):2727-37. doi: 10.3109/14767058.2015.1103729 Go to original source... Go to PubMed...
  45. Lee J, Romero R, Kim SM, Chaemsaithong P, Park CW, Park JS, Jun JK,Yoon BH. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med 2016;29(5):707-20. doi: 10.3109/14767058.2015.1020293 Go to original source... Go to PubMed...
  46. Gomez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, Espinoza J, Chaiworapongsa T, Gonzalez R, Iams JD, Rojas I. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med 2007;20(2):167-73. doi: 10.1080/14767050601135485. Go to original source... Go to PubMed...
  47. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81(1):1-5. doi: 10.1189/jlb.0306164 Go to original source... Go to PubMed...
  48. Romero R, Chaiworapongsa T, Alpay Savasan Z, Xu Y, Hussein Y, Dong Z, Kusanovic JP, Kim CJ, Hassan SS. Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med 2011;24(12):1444-55. doi: 10.3109/14767058.2011.591460 Go to original source... Go to PubMed...
  49. Cobo T, Kacerovsky M, Palacio M, Hornychova H, Hougaard DM, Skogstrand K, Jacobsson B. Intra-amniotic inflammatory response in subgroups of women with preterm prelabor rupture of the membranes. PLoS One 2012;7(8):e43677. doi: 10.1371/journal.pone.0043677 Go to original source... Go to PubMed...
  50. Tchirikov M, Zhumadilov Z, Winarno AS, Haase R, Buchmann J. Treatment of Preterm Premature Rupture of Membranes with Oligo-/Anhydramnion Colonized by Multiresistant Bacteria with Continuous Amnioinfusion and Antibiotic Administrations through a Subcutaneously Implanted Intrauterine Port System: A Case Report. Fetal Diagn Ther 2017;42(1):71-6. doi: 10.1159/000438483 Go to original source... Go to PubMed...
  51. Garcia-Munoz Rodrigo F, Galan Henriquez G, Figueras Aloy J, Garcia-Alix Perez A. Outcomes of very-low-birth-weight infants exposed to maternal clinical chorioamnionitis: a multicentre study. Neonatology 2014;106(3):229-34. doi: 10.1159/000363127 Go to original source... Go to PubMed...
  52. Walker MW, Picklesimer AH, Clark RH, Spitzer AR, Garite TJ. Impact of duration of rupture of membranes on outcomes of premature infants. J Perinatol 2014;34(9):669-72. doi: 10.1038/jp.2014.73 Go to original source... Go to PubMed...
  53. Test G, Levy A, Wiznitzer A, Mazor M, Holcberg G, Zlotnik A, Sheiner E. Factors affecting the latency period in patients with preterm premature rupture of membranes. Arch Gynecol Obstet 2011;283(4):707-10. doi: 10.1007/s00404-010-1448-7. Go to original source... Go to PubMed...
  54. Goya M, Bernabeu A, Garcia N, Plata J, Gonzalez F, Merced C, Llurba E, Suy A, Casellas M, Carreras E, Cabero L. Premature rupture of membranes before 34 weeks managed expectantly: maternal and perinatal outcomes in singletons. J Matern Fetal Neonatal Med 2013;26(3):290-3. doi: 10.3109/14767058.2012.733779 Go to original source... Go to PubMed...
  55. Baser E, Aydogan Kirmizi D, Ulubas Isik D, Ozdemirci S, Onat T, Serdar Yalvac E, Demirel N, Moraloglu Tekin O. The effects of latency period in PPROM cases managed expectantly. J Matern Fetal Neonatal Med 2020;33(13):2274-83. doi: 10.1080/14767058.2020.1731465 Go to original source... Go to PubMed...
  56. Arora P, Bagga R, Kalra J, Kumar P, Radhika S, Gautam V. Mean gestation at delivery and histological chorioamnionitis correlates with early-onset neonatal sepsis following expectant management in pPROM. J Obstet Gynaecol 2015;35(3):235-40. doi: 10.3109/01443615.2014.958143 Go to original source... Go to PubMed...
  57. Stepan M, Cobo T, Maly J, Navratilova M, Musilova I, Hornychova H, Jacobsson B, Kacerovsky M. Neonatal outcomes in subgroups of women with preterm prelabor rupture of membranes before 34 weeks. J Matern Fetal Neonatal Med 2016;29(14):2373-7. doi: 10.3109/14767058.2015.1086329 Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.